Tender detail
Pharmaceutical rebate agreement for betamethasone + clotrimazole
Summary
The tender concerns a pharmaceutical rebate agreement for the active substance betamethasone + clotrimazole (ATC D01AC20). The bidder should note that DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible for the period 01/09/2026 to 31/08/2028, with an option to extend the agreement once by 12 months.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.